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Abstract 
Thanks to a smart regiospecific N-functionalization, a pyclen based ligand bearing one picolinate and two 
acetate arms organized in a dissymmetric manner was synthesized for Y
3+
 complexation, and compared to its 
symmetric analogue. The nature of the capping bonds around the metal coordination environment has a 
dramatic effect on the properties of the chelate, the 
nat
Y
3+
 and 
90
Y
3+
 dissymmetric derivatives presenting 
enhanced thermodynamic stability and kinetic inertness. 
Keywords: thermodynamic stability; DFT calculations; yttrium complexes; pyclen ligands; radiotherapy 
 
A large variety of metal radioisotopes is currently used in nuclear medicine due to their important diagnostic 
or therapeutic applications. Among the radioisotopes available for therapy, 
90
Y (t1/2 = 64.2 h, Eβ− = 2.28 
MeV) is one of the most interesting β− radioisotopes,1 especially for the treatment of large solid tumors.2 
Similar to the lanthanide(III) ions, Y
3+
 typically forms eight- or nine-coordinated chelates with a preference 
for hard donor atoms such as negatively charged oxygen atoms of carboxylate/phosphonate groups and 
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amine nitrogen atoms.
3
 Polyazamacrocycles, such as tacn or cyclen,
ii
 are recognized as convenient platforms 
for the coordination of lanthanide cations after a specific functionalization of their amine groups.
4
 Among the 
current azamacrocycles, derivatives of the 12-membered tetraazamacrocyclic ligand that include a pyridine 
unit within the ring, often denoted as pyclen (or 12-py-N4),
ii
 have been less explored. However, the presence 
of the aromatic moiety confers to the macrocyclic backbone an important rigidity that constrains the overall 
structure and consequently may lead to unexpected properties compared to its cyclen analogue. For example, 
the aminocarboxylic acid derivative of pyclen, pcta,
ii
 forms stable and neutral lanthanide complexes. Its 
Gd
3+
 chelate presents a relatively high proton relaxivity due to the presence of two coordinated water 
molecules endowed with fast water exchange rates, which makes this complex and related systems 
interesting alternatives to [Gd(dota)]
− ii
 as non-specific MRI contrast agents.
5
 In addition, pcta has been found 
to present fast chelation kinetics under mild conditions,
6
 making pcta and its derivatives attractive candidates 
for applications in nuclear medicine. A fast complexation of the radioisotope compared to its half-life is of 
crucial importance to obtain high radiolabelling yields, in particular because of the low concentrations 
employed and the “soft” conditions that can be tolerated by the biomolecules used for targeting purposes.7 
Pyridinecarboxylate (picolinate) groups are bidentate coordinating units that are known to display 
extraordinary coordination properties toward different metal ions,
8
 including lanthanides,
9
 particularly when 
appended on macrocyclic scaffolds.
10
 Thus, we firstly thought it judicious to conjugate the favourable 
binding properties of the pyclen skeleton and the pyridinecarboxylate group to obtain neutral yttrium(III) 
chelates that could be an interesting alternative to the negatively charged [Y(dota)]
−
. Furthermore, we sought 
to investigate the effect that a different spatial arrangement of the coordinating functions may have on the 
properties of the complexes. Thus, two new regio-isomeric pyclen-based ligands bearing one picolinate and 
two acetate pendant arms, organized either in a symmetric (L1) or non-symmetric (L2) manner, were 
synthesized, and their coordination properties towards yttrium(III) were compared (Fig. 1). 
 
 
Fig. 1. Structures of the pyclen-based mono-picolinate ligands. 
 
L1 was obtained by two successive alkylations controlled by protection/deprotection sequences starting 
from N
3
-Boc-pyclen, which was previously described by Siaugue et al.
11
 (see the ESI
i
). The synthesis of the 
dissymmetric regioisomer L2 was more challenging and required the development of a new route inspired by 
the acylation of cyclam with diethyl oxalate, which allows a selective cis-N
2
-N
3
-dialkylation.
12
 After the 
neutralisation of pyclen·3HCl, pyclen oxalate (1) was synthesized in good yield (90%) by acylation with 
diethyl oxalate in MeOH (Fig. 2). The free amine function was then reacted with methyl 6-
(chloromethyl)picolinate to lead quasi-quantitatively to 2. After hydrolysis of the oxalate bridge and 
esterification of the carboxylic acid, the two other amine functions were alkylated with the acetate arm. A 
final hydrolysis step provided L2. The relatively low yields of the last step obtained for the two ligands are 
related to the difficulties found during HPLC purification. 
 
 
 
Fig. 2. Synthesis of the dissymmetric pyclen-based mono-picolinate L2. 
 
The yttrium(III) complexes were synthesized in water at pH 5 and isolated in very good yields (∼90%). Both 
regioisomers and their complexes were characterized by 
1
H and 
13
C NMR in D2O (ESI
i
). The assignments of 
the proton signals (Tables S1–S4, ESIi) were based on HMQC and HMBC 2D heteronuclear experiments as 
well as standard 2D homonuclear COSY experiments. At 25 °C, YL2 presents sharp signals with methylene 
resonances showing a diastereotopic pattern (see Fig. S2 in the ESI
i
). In fact, all the non-aromatic protons 
located on the same carbon atom give two signals, which indicates the presence of a single diastereoisomer 
in solution with no fluxional behaviour within the NMR timescale. YL1 shows however broad signals in the 
region 2–5 ppm at room temperature, which become sharp at 55 °C. At the latter temperature, the number 
of 
1
H and 
13
C NMR signals is consistent with an effective Cs symmetry, likely resulting from a fast 
interconversion between enantiomeric forms of the complex by rotation of the pendant arms and inversion of 
the macrocyclic ring (see Fig. S3 and S4 in the ESI
i
). 
The thermodynamic protonation constants of L1 and L2 and the stability constants of their complexes with 
Y
3+
 were determined at 25 °C in 0.15 M NaCl using potentiometric titration and 
1
H-relaxometry (with the 
use of Gd
3+
 as a competitor), respectively. Both L1 and L2 present a protonation behaviour similar to H3pcta. 
The first protonation constant (log K1 = 9.69 and 10.43 for L1 and L2 respectively) corresponds to the 
protonation of the N atom trans to the pyridine ring.
13
 The second protonation induces a rearrangement of the 
protonated sites, so that the two N atoms cis to the pyridine unit are protonated (log K2 = 7.63 and 6.47 
for L1 and L2 respectively).
6
 As for previous systems, a decreasing basicity occurring when carboxylate 
groups are replaced by picolinate moieties is observed.
14
 The third protonation process is likely associated 
with the protonation of the picolinate unit, while the fourth protonation constant is attributed to a carboxylate 
group (Table S5, ESI
i
). The protonation constants show that L1 and L2 have a similar overall basicity, which 
is lower than that of H4dota.
15
 The thermodynamic stability of the yttrium(III) complexes YL1 and YL2 was 
determined by competition with Gd
3+
 using the relaxometric technique (Table 1and in the ESI,
i
 Table S5 and 
Fig. S5).
16
 The stability constant obtained for YL2 is very high and significantly higher than that of YL1 (log
KYL = 22.44 and 19.89 respectively), in spite of a similar basicity of the ligands. In addition, the stability 
constant of YL2 is higher than that of Y(pcta) (log KYL = 20.28 determined at 25 °C by using 1.0 M KCl), 
although lower than that of [Y(dota)]
−
 (log KYL = 24.9). However, a comparison of the complexation ability 
 
 
of ligands with different basicity might be misleading if the competition of protons is not taken into account. 
A better comparison is provided by the pM values, which were calculated for the Y
3+
 complexes 
of L1, L2 and related ligands at pH 7.4 (Table 1). The pY value obtained for YL1 (pY = 18.14) is one log 
unit higher than that of Y(pcta) (pY = 17.0) and approaching that of [Y(dota)]
−
 (pY = 18.9). More 
remarkably, the pY value obtained for YL2 (pY = 20.33) is much higher than those of the reference chelates 
Y(pcta) and [Y(dota)]
−
. These results highlight the dramatic effect that the arrangement of the ligand donor 
atoms of the chelators has on the stability of the complexes, conferring on L2higher Y
3+
 complexation 
properties than the current reference chelators. 
 
Table 1. Stability constants of Y
3+
 complexes formed with pyclen based 
 mono-picolinates (25 °C, 0.15 M NaCl) and related ligands. 
 
 L1 L2 pcta dota 
log KYL 19.89(1)
a
 22.44(2)
a
 20.28
b
 24.09
c
 
pY
d
 18.14 20.33 17.0 18.9 
 
a
 Stability constants of the Y
3+
 complexes were determined by Gd
3+
 competition. 
b
 Ref. 6 (25 
°C, 1.0 M KCl). 
c
 Ref. 17 (25 °C, 0.1 M Me4NNO3). 
d
 Calculated at pH = 7.4 for 100% 
excess of ligands with [Y
3+
]tot = 10
−5
 M based on stability constants given in this table. 
 
 
Another essential feature that must fulfil chelate-based radiopharmaceuticals is a good kinetic inertness in 
order to avoid the release of the metal ion in vivo. A preliminary assessment of the kinetic inertness of a 
chelate can be carried out by studying the dissociation of the complex in acidic media, which provides 
interesting information on the behaviour of a complex in very competitive media. The acid-assisted 
dissociation of YL1 and YL2 was studied in 0.5, 1 and 2 M HCl solutions at 25 °C by following the changes 
in the π–π* absorption band of the complexes in the UV range (Fig. S6 and S7 in the ESIi). The different N-
functionalization pattern has a very significant impact on the chelate properties, as an impressive gain of 
kinetic inertness is observed for the yttrium(III) complex of the dissymmetrical pyclen-based mono-
picolinate L2 compared to its symmetric analogue L1 (Table 2). One can especially note that the inertness of 
YL2 is significant with respect to the reference Y(pcta)
6
complex. 
 
Table 2. Determined half-times (in minutes) of dissociation of YL1 and YL2 in HCl media. 
 
 HCl 0.5 M HCl 1 M HCl 2 M 
YL1 55 27 11 
YL2 1014 357 137 
Y(pcta)6 31.9 19.6 12.7 
 
 
In the absence of crystallographic data, a DFT study was undertaken to rationalise the very different stability 
and dissociation kinetics of the YL1 and YL2 complexes. Our calculations provide optimised structures 
showing nine-coordinate Y
3+
 ions, where coordination number nine is completed by the presence of a water 
molecule (Fig. 3). During the calculations two second-sphere water molecules were included in order to 
 
 
obtain more accurate bond distances involving the coordinated water molecules.
18
 The two isomeric 
complexes present tricapped trigonal prismatic coordination environments, which are however defined by 
different donor atoms of the ligand in each case. In YL1, the three capping positions of the polyhedron are 
taken by the nitrogen atom of the picolinate unit (N5), an amine N donor atom (N4) and the oxygen atom of 
a carboxylate group (O2). The capping positions in YL2 are delineated by the amine nitrogen atoms N2 and 
N4 and the oxygen atom of the coordinated water molecule (O1). The bound water molecule presents a much 
shorter distance in YL1 (2.379 Å) than in YL2 (2.490 Å), which is in line with the capping position occupied 
by the water molecule in the latter. The distances involving the metal ion and oxygen atoms of carboxylate 
groups are rather similar to YL2 (2.28–2.33 Å). However, two of these distances are considerably shorter 
(2.31–2.32 Å) than the third one (Y–O2 = 2.40 Å) in YL1, which appears to be related to the capping 
position occupied by this donor atom. Indeed, we have recently shown that water molecules occupying 
capping positions in the coordination sphere are particularly labile because they are hindered by the 
environment.
19
 The results reported here suggest that the labile capping bond phenomenon can be extended 
to donor atoms of the ligand, other than water molecules. The weak coordination of a carboxylate group at a 
capping position explains the lower stability of the YL1 complex with respect to YL2, as also confirmed by 
the relative free energy obtained from DFT, which favours YL2 by 20.2 kJ mol
−1
. The fluxional behaviour of 
YL1 evidenced by NMR measurements can also be attributed to the presence of a weakly bound carboxylate, 
which likely facilitates dynamic processes involving the rearrangement of the ligand donor atoms around the 
metal ion. The location of a negatively charged carboxylate at a capping position in YL1 also justifies the 
faster proton-assisted dissociation kinetics, which are likely the result of an easier decoordination of the 
carboxylate group upon protonation. This proton is then transferred to a nearby amine nitrogen atom, which 
in turn triggers the complex dissociation. 
 
 
Fig. 3. Optimized structures of the YL1(H2O)·2H2O (top) and YL2(H2O)·2H2O (bottom) systems obtained with DFT 
calculations. Bond distances (Å), YL1(H2O)·2H2O: Y–N1 2.572, Y–N2 2.614, Y–N3 2.709, Y–N4 2.652, Y–N5 2.530, 
Y–O1 2.379, Y–O2 2.401, Y–O3 2.313 and Y–O4 2.320. YL2(H2O)·2H2O: Y–N1 2.602, Y–N2 2.665, Y–N3 2.594, 
Y–N4 2.593, Y–N5 2.465, Y–O1 2.490, Y–O2 2.295, Y–O3 2.280 and Y–O4 2.327. 
 
 
90
Y radiolabelling experiments were performed with L1 and L2 to evaluate their labelling rates and 
efficiencies under different conditions (in 0.1 M HCl (pH = 3) or in acetate buffer (pH = 4.65–9)). The 
optimal radiolabelling conditions were then determined by varying the reaction time, the temperature, the 
concentration and the pH (Fig. S8, ESI
i
). The influence of the temperature was evaluated with CL = 10
−3
 M at 
pH 5.2. A radiochemical purity (RCP) of 96% was obtained with L2 when heating at 60 °C, while the RCP 
dropped to 79% at rt. High RCP (85%) with L1 could be obtained only after heating up to 100 °C (Fig. S8B, 
ESI
i
). The optimal conditions for the formation of the 
90
YL complexes were found to be a reaction time of 15 
min, CL = 0.1–1 mM and pH = 3.0–7.0 for L2 and 4.7–5.2 for L1. These results clearly underline the faster 
and more efficient radiolabelling of L2compared to L1 with 
90
Y. The 
90
Y radiolabelling of L2 is as efficient 
as the one performed under similar conditions to dota (
90
Y-acetate, pH = 7.5, 15 min at 60 °C, CL = 1 mg 
mL
−1
).
20
 The stabilities of the 
90
YL complexes were studied both in human serum and in an aqueous solution 
containing 0.1 M edta (Fig. 4). 
90
YL2 was found to be very stable both in serum and in the presence of an 
excess of edta, with no decrease of its RCP after 72 h. Again, 
90
YL1 is less stable with a progressive 
dissociation in human serum solution (Fig. 4a) and an immediate decrease of RCP in the edta solution. These 
results are in perfect agreement with the thermodynamic stability and kinetic inertness studies performed 
with the cold analogues, which already underlined the superior stability of YL2. 
 
 
Fig. 4. Stability of 
90
YL complexes in (a) human serum, (b) edta 0.1 M. 
 
 
 
In conclusion, we synthesized the two first mono-picolinate di-acetate pyclen derivatives and proved their 
very interesting yttrium(III) complexation properties. We developed a new regiospecific N-functionalization 
of the pyclen framework, which allows tuning the arrangement of the pendant arms. This led to the 
preparation of the dissymmetric L2 chelator, which forms a very stable and inert Y
3+
 complex, representing a 
very attractive alternative to dota for 
90
Y
3+
 radiotherapy applications. The different arrangement of the donor 
atoms of L1 and L2 leads to very different complexation properties. For instance, the YL1complex was 
found to be considerably more labile with respect to dissociation, which showcases the labile capping bond 
phenomenon. However, the YL1 complex also shows a considerably lower thermodynamic stability with 
respect to YL2, which can be attributed to a weaker coordination of a carboxylate group occupying a 
capping position in YL1. Therefore, the labile capping bond phenomenon introduced recently
19
 has profound 
consequences not only on the water exchange and proton-assisted dissociation rates of the complexes, but 
also on their thermodynamic stabilities. Since the weak coordination of ligands or donor atoms at capping 
positions affects both the kinetic and thermodynamic properties, we propose to rename this phenomenon as 
the capping bond effect. 
 
Acknowledgments 
R. T. acknowledges the Ministère de l'Enseignement Supérieur et de la Recherche, the Centre National de la 
Recherche Scientifique and the “Service Commun” of NMR facilities of the University of Brest. R. T. and O. 
R. also thank the Guerbet group and the Association Nationale de la Recherche et de la Technologie for the 
CIFRE fellowship. C. P.-I. thanks Centro de Supercomputación de Galicia (CESGA) for providing the 
computer facilities. Gy. T. is grateful for support arriving from the Hungarian Scientific Research Fund 
(NKFIH K-120224 project) and for the János Bolyai Research Scholarship of the Hungarian Academy of 
Sciences. The research was also supported in a part by the EU and co-financed by the European Regional 
Development Fund under the project GINOP-2.3.2-15-2016-00008. N. L. acknowledges Labex IRON (Grant 
No. ANR-11-LABX-0018). 
 
References 
1. E. W. Price and C. Orvig, Chem. Soc. Rev., 2014, 43, 260–290. 
2. D. E. Milenic, E. D. Brady and M. W. Brechbiel, Nat. Rev., 2004, 3, 488. 
3. P. Mieville, S. Jannin, L. Helm and G. Bodenhausen, J. Am. Chem. Soc., 2010, 132, 5006. 
4. G. J. Stasiuk and N. J. Long, Chem. Commun., 2013, 49, 2732; X. Liang and P. J. Sadler, Coord. 
Chem. Rev., 2004,33, 246; T. Joshi, B. Graham and L. Spiccia, Acc. Chem. Res., 2015, 48, 2366; E. 
K. Barefield, Coord. Chem. Rev., 2010, 254, 1607; N. Cakic, S. Gunduz, R. Rengarasu and G. 
Angelovski, Tetrahedron Lett., 2015, 56, 759. 
5. J.-M. Siaugue, F. Segat-Dioury, A. Favre-Réguillon, V. Wintgens, C. Madic, J. Foos and A. Guy, J. 
Photochem. Photobiol., A, 2003, 156, 23. 
6. G. Tircso, Z. Kovacs and A. D. Sherry, Inorg. Chem., 2006, 45, 9269. 
7. S. R. Banerjee, M. Pullambhatla, C. A. Foss, S. Nimmagadda, R. Ferdani, C. J. Anderson, R. C. 
Mease and M. G. Pomper, J. Med. Chem., 2014, 57, 2657; S. Ait-Mohand, P. Fournier, V. Dumulon-
Perreault, G. E. Kiefer, P. Jurek, C. L. Ferreira, F. Benard and B. Guerin, Bioconjugate Chem., 
 
 
2011, 22, 1729; M. S. Cooper, M. T. Ma, K. Sunassee, K. P. Shaw, J. D. Williams, R. L. Paul, P. S. 
Donnelly and P. J. Blower, Bioconjugate Chem., 2012, 23, 1029. 
8. E. Boros, C. L. Ferreira, J. F. Cawthray, E. W. Price, B. O. Patrick, D. W. Wester, M. J. Adam and 
C. Orvig, J. Am. Chem. Soc., 2010, 132, 15726; E. W. Price, J. F. Cawthray, G. A. Bailey, C. L. 
Ferreira, E. Boros, M. J. Adam and C. Orvig, J. Am. Chem. Soc., 2012, 134, 8670; G. A. Bailey, E. 
W. Price, B. M. Zeglis, C. L. Ferreira, E. Boros, M. J. Lacasse, B. O. Patrick, J. S. Lewis, M. J. 
Adam and C. Orvig, Inorg. Chem., 2012, 51, 12575; E. Boros, J. F. Cawthray, C. L. Ferreira, B. O. 
Patrick, M. J. Adam and C. Orvig, Inorg. Chem., 2012, 51, 6279. 
9. L. Charbonnière, N. Weibel, P. Retailleau and R. Ziessel, Chem. – Eur. J., 2007, 13, 346; L. 
Charbonnière, S. Mameri, P. Kadjane, C. Platas-Iglesias and R. Ziessel, Inorg. Chem., 2008, 47, 
3748; M. Regueiro-Figueroa, B. Bensenane, E. Ruscsak, D. Esteban-Gómez, L. J. Charbonniere, G. 
Tircso, I. Toth, A. de Blas, T. Rodríguez-Blas and C. Platas-Iglesias, Inorg. Chem., 2011, 50, 4125; 
A. Nonat, C. Gateau, P. H. Fries and M. Mazzanti, Chem. – Eur. J., 2006, 12, 7133; A. Nonat, P. H. 
Fries, J. Pecaut and M. Mazzanti, Chem. – Eur. J., 2007, 13, 8489; N. Chatterton, C. Gateau, M. 
Mazzanti, J. Pecaut, A. Borel, L. Helm and A. E. Merbach, Dalton Trans., 2005, 1129; S. Mameri, 
L. Charbonnière and R. Ziessel, Tetrahedron Lett., 2007, 48, 9132; A. Nonat, M. Giraud, C. Gateau, 
P. H. Fries, L. Helm and M. Mazzanti, Dalton Trans., 2009, 8033. 
10. R. Ferreiros-Martinez, D. Esteban-Gomez, E. Toth, A. de Blas, C. Platas-Iglesias and T. Rodriguez-
Blas, Inorg. Chem., 2011,50, 3772; R. Ferreiros-Martinez, D. Esteban-Gomez, A. de Blas, C. Platas-
Iglesias and T. Rodriguez-Blas, Inorg. Chem., 2009, 48, 11821; A. Rodríguez-Rodríguez, D. 
Esteban-Gómez, A. de Blas, T. Rodríguez-Blas, M. Fekete, M. Botta, R. Tripier and C. Platas-
Iglesias, Inorg. Chem., 2012, 51, 2509; A. Rodríguez-Rodríguez, D. Esteban-Gómez, R. Tripier, G. 
Tircsó, Z. Garda, I. Tóth, A. de Blas, T. Rodríguez-Blas and C. Platas-Iglesias, J. Am. Chem. Soc., 
2014, 136, 17954. 
11. J. Siaugue, F. Segat-Dioury, I. Sylvestre, A. Favre-Réguillon, J. Foos, C. Madic and A. Guy, 
Tetrahedron, 2001, 57, 4713. 
12. F. Bellouard, F. Chuburu, N. Kervarec, L. Toupet, S. Triki, Y. Le Mest and H. Handel, J. Chem. 
Soc., Perkin Trans. 1, 1999, 3499. 
13. S. Aime, M. Botta, S. G. Crich, G. B. Giovenzana, G. Jommi, R. Pagliarin and M. Sisti, Inorg. 
Chem., 1997, 36, 2992. 
14. N. Chatterton, C. Gateau, M. Mazzanti, J. Pecaut, A. Borel, L. Helm and A. E. Merbach, Dalton 
Trans., 2005, 1129. 
15. A. Takács, R. Napolitano, M. Purgel, A. C. Bényei, L. Zékány, E. Brücher, I. Tóth, Z. Baranyai and 
S. Aime, Inorg. Chem., 2014,53, 2858. 
16. A. Rodríguez-Rodríguez, Z. Garda, E. Ruscsák, D. Esteban-Gómez, A. de Blas, T. Rodríguez-Blas, 
L. M. P. Lima, M. Beyler, R. Tripier, G. Tircsó and C. Platas-Iglesias, Dalton Trans., 2015, 5017. 
17. C. J. Broan, J. P. L. Cox, A. S. Craig, R. Kataky, D. Parker, A. Harrison, A. M. Randall and G. 
Ferguson, J. Chem. Soc., Perkin Trans. 2, 1991, 87. 
18. M. Regueiro-Figueroa and C. Platas-Iglesias, J. Phys. Chem. A, 2015, 119, 6436. 
19. A. Rodríguez-Rodríguez, M. Regueiro-Figueroa, D. Esteban-Gómez, T. Rodríguez-Blas, V. Patinec, 
R. Tripier, G. Tircso, F. Carniato, M. Botta and C. Platas-Iglesias, Chem. – Eur. J., 2017, 23, 1110. 
 
 
20. U. Pandey, A. Mukherjee, H. D. Sarma, T. Das, M. R. A. Pillai and M. Venkatesh, Appl. Radiat. 
Isot., 2002, 57, 313. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
i
 Electronic supplementary information (ESI) available: Experimental section and analytical data for synthesis, 
coordination chemistry and radiolabelling. See DOI: 10.1039/c7cc05088g. 
ii
 Full names: tacn (1,4,7-triazacyclononane), cyclen (1,4,7,10-tetraazacyclododecane), pyclen (3,6,9,15 
tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene), pcta (3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-
3,6,9-triacetic acid), dota (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). 
